Protein turnover and energy expenditure increase during exogenous nutrient availability in sickle cell disease
Open Access
- 1 September 1998
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The American Journal of Clinical Nutrition
- Vol. 68 (3) , 607-614
- https://doi.org/10.1093/ajcn/68.3.607
Abstract
In the present study, energy expenditure (EE) and rates of whole-body protein, glucose, and lipid metabolism were assessed in 8 African American sickle cell disease (SCD) patients and in 6 healthy African American control subjects during the infusion of amino acids, glucose, and lipid. Whole-body protein, glucose, and lipid kinetics were estimated by using L-[1-(13)C]leucine, D-[6,6-(2)H2]glucose, and [(2)H5]glycerol, respectively. After a 2-h tracer equilibration period and a 0.5-h basal period, nutrients were administered intravenously for 3 h with 16% of the energy as protein, 52% as carbohydrate, and 32% as fat. Breath and blood were collected during the last 30 min of nutrient infusion and EE was measured by indirect calorimetry. EE was 14% greater (P < or = 0.05) in SCD patients [145.0 +/- 3.5 kJ x kg fat-free mass (FFM)(-1) x d(-1)] than in control subjects (126.8 +/- 3.8 kJ x kg FFM(-1) x d(-1)). Whole-body protein breakdown (4.4 +/- 0.4 compared with 3.1 +/- 0.1 mg x kg FFM(-1) x min(-1), P < or = 0.05) and protein synthesis (4.6 +/- 0.4 compared with 3.2 +/- 0.1 g x kg FFM(-1) x min(-1), P < or = 0.05) were 42% and 44% greater, respectively, in the SCD patients than in control subjects, but whole-body amino acid oxidation (0.90 +/- 0.05 compared with 1.03 +/- 0.09 mg x kg FFM(-1) x min(-1)) was not significantly different between the 2 groups. Whole-body glucose and lipid kinetics did not differ significantly between the groups. EE increased in SCD patients during exogenous nutrient availability, and the additional energy required for the accelerated rates of whole-body protein breakdown and synthesis made a significant contribution to the increase in EE. These metabolic aberrations may increase the dietary energy and protein requirements of SCD patients.Keywords
This publication has 23 references indexed in Scilit:
- The role of glucagon in the control of protein and amino acid metabolism in vivoMetabolism, 1994
- Nutritional Status and Dietary Intake of Children with Sickle Cell AnemiaJournal of Pediatric Hematology/Oncology, 1992
- Nitrogen Metabolism in Sickle Cell Anemia: Free Amino Acids in Plasma and UrineThe Lancet Healthy Longevity, 1990
- Automated measurement of the concentration and13C enrichment of carbon dioxide in breath and blood samples using the finnigan MAT breath gas analysis systemJournal of Mass Spectrometry, 1988
- Assessment of Energy Expenditure and Fuel Utilization in ManAnnual Review of Nutrition, 1987
- GROWTH RETARDATION IN SICKLE-CELL DISEASE TREATED BY NUTRITIONAL SUPPORTThe Lancet, 1985
- Relationship of plasma leucine and α-ketoisocaproate during a L-[1-13C]leucine infusion in man: A method for measuring human intracellular leucine tracer enrichmentMetabolism, 1982
- II. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in manLife Sciences, 1981
- Protein turnover in growing pigs. Effects of age and food intakeBritish Journal of Nutrition, 1980
- Gene Mutations in Human Hæmoglobin: the Chemical Difference Between Normal and Sickle Cell HæmoglobinNature, 1957